Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Oncotarget|February 18, 2020
Tumor suppressor genes and allele-specific expression: mechanisms and significanceEvan A Clayton, Shareef Khalid, Dongjo Ban, et al.Biorxiv : the Preprint Server for Biology|September 4, 2024
Macrophage WDFY3, a protector against autoimmunityXun Wu, Ziyi Wang, Katherine R Croce, et al.Scientific Reports|February 25, 2018
ATLANTIS - Attractor Landscape Analysis Toolbox for Cell Fate Discovery and ReprogrammingOsama Shiraz Shah, Muhammad Faizyab Ali Chaudhary, Hira Anees Awan, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 2026
Perk Is Dispensable for Smooth Muscle Cell Phenotype Switching in AtherosclerosisLucie Y Zhu, Chenyi Xue, Alexander C Bashore, et al.Nature Metabolism|September 27, 2025
A non-apoptotic caspase-8-meteorin pathway in hepatocytes promotes MASH fibrosisXiaobo Wang, Mary P Moore, Hongxue Shi, et al.Hepatology (Baltimore, Md.)|May 22, 2024
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulationMary P Moore, Xiaobo Wang, John Paul Kennelly, et al.Plos Genetics|March 5, 2025
Human CD33 deficiency is associated with mild alteration of circulating white blood cell countsJohn Dominy, Jirong Bai, Christopher Koch, et al.Plos Genetics|April 5, 2022
Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass indexAllan Gurtan, John Dominy, Shareef Khalid, et al.Scientific Reports|April 29, 2026
Unraveling the physiological impact of ANGPTL8 loss-of-function variants in humansArkan Abadi, Yan Q Chen, Shareef Khalid, et al.Diabetologia|September 29, 2025
Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell functionLindsey B Lamarche, Christopher Koch, Shareef Khalid, et al.Pageof 2